Sign in

CIK 0001453593

  • Non-accelerated filer
  • Smaller reporting company

Xtant Medical Holdings, Inc.

Sign in to watch
Ticker
XTNT
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205313323
Phone
+1 406-388-0480
Business address
664 CRUISER LANE, BELGRADE, MT, 59714
Former names
Bacterin International Holdings, Inc., K KITZ INC
  1. 4 Grant or award Director acquired 20,101 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $2.34 ($11,700)
  6. 4 Other acquisition Director acquired 1,700 shares (code L)
  7. 4 Open-market buy Director bought 3,300 shares at an average $2.83 ($9,343)
  8. 4 Open-market buy EVP & Chief Scientific Officer bought 2,000 shares at an average $2.99 ($5,983)
  9. 4 Open-market buy Director bought 5,000 shares at an average $3.00 ($14,998)
  10. 4 Open-market buy EVP & Chief Scientific Officer bought 2,000 shares at an average $2.90 ($5,805)
  11. 4 Open-market buy Chief Executive Officer bought 3,000 shares at $2.80 ($8,400)
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Director bought 6,793 shares at $3.68 ($24,998)
  14. 4 Open-market buy Director bought 10,869 shares at $3.68 ($39,998)
  15. 4 Open-market buy Director bought 30,000 shares at $3.68 ($110,400)
  16. 4 Open-market buy Director bought 10,869 shares at $3.68 ($39,998)
  17. 4 Open-market buy Chief Executive Officer bought 81,522 shares at $3.68 ($300,001)
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 9 of 16 · 319 filings